Biotechnology Alkermes Presents ARTISTRY-1 Data at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting June 1, 2022
Biotechnology Apellis Announces Submission of New Drug Application to the FDA for Pegcetacoplan for Geographic Atrophy June 1, 2022
Biotechnology Axsome Therapeutics Announces Late-Breaking Presentations of Positive Results of the EVOLVE Trial of AXS-05 in Major Depressive Disorder After Prior Treatment Failures at the American Society of Clinical Psychopharmacology (ASCP) 2022 Annual Meeting June 1, 2022
Biotechnology ChemoCentryx Announces Abstracts at June Rheumatology, Oncology and Nephrology Conferences May 31, 2022
Biotechnology Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Axsome Therapeutics, Inc. (AXSM) Investors of Class Action and Encourages Shareholders to Contact the Firm May 31, 2022
Search
Biotechnology
